Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Stomach Neoplasms 2 Solid Tumor 1 Sarcoma, Clear Cell 1 Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 133 Gemcitabine 101 Paclitaxel 100 Carboplatin 84 Nivolumab 66 Docetaxel 62 Bevacizumab 62 Cisplatin 57 Pemetrexed 50 Fluorouracil 49 Cyclophosphamide 41 Cetuximab 41 trametinib 38 venetoclax 37 Leucovorin 37 Irinotecan 37 Sorafenib 35 Capecitabine 35 Ipilimumab 33 Dexamethasone 32 atezolizumab 31 Erlotinib Hydrochloride 28 130-nm albumin-bound paclitaxel 28 Drug Therapy 27 Epoetin Alfa 26 Doxorubicin 25 Oxaliplatin 24 Albumin-Bound Paclitaxel 24 Prednisone 23 Rituximab 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Neoplasms × AMG 337 × Clear all

NCT01253707 2022-11-07

A Study of AMG 337 in Subjects With Advanced Solid Tumors

Amgen

Phase 1 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡